478 related articles for article (PubMed ID: 445411)
1. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
Carry PJ; Prescott DM; Ogilvie GK
Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
[TBL] [Abstract][Full Text] [Related]
2. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
Belokhvostov AS; Zelenkova NK
Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
[TBL] [Abstract][Full Text] [Related]
3. Different behaviour of thymus in hosts bearing skin homografts or ehrlich ascites carcinoma.
Simu G; Kiricuţă I; Crivii MS; Nestor D
Arch Geschwulstforsch; 1976; 46(3):183-6. PubMed ID: 9920
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
Yumura M
Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
[TBL] [Abstract][Full Text] [Related]
5. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
Loring M; Schlesinger M
Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
[No Abstract] [Full Text] [Related]
6. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
[TBL] [Abstract][Full Text] [Related]
7. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
Yarkoni E; Bekierkunst A; Asselineau J; Toubiana R; Toubiana MJ; Lederer E
J Natl Cancer Inst; 1973 Aug; 51(2):717-20. PubMed ID: 4765386
[No Abstract] [Full Text] [Related]
8. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Ehrlich ascites tumors in mice by minute virus of mice.
Guetta E; Graziani Y; Tal J
J Natl Cancer Inst; 1986 Jun; 76(6):1177-80. PubMed ID: 3458953
[TBL] [Abstract][Full Text] [Related]
10. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
Bregula U; Slowikowska G; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
[No Abstract] [Full Text] [Related]
11. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
12. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
Tsai TH; Burns RE; Scheving LE
Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
[TBL] [Abstract][Full Text] [Related]
13. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
14. Surface antigen on Ehrlich ascites tumor cells.
Pessina A; Brambilla P; Mocarelli P
Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
[TBL] [Abstract][Full Text] [Related]
15. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
16. Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
Lapointe JR; Portelance V
Cancer Res; 1978 Aug; 38(8):2295-300. PubMed ID: 208766
[TBL] [Abstract][Full Text] [Related]
17. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
Yasuhira K
Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
[No Abstract] [Full Text] [Related]
18. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
Dabrowska B; Janik P; Radwański Z; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
[No Abstract] [Full Text] [Related]
19. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
Janik P; Dabrowski M; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
[No Abstract] [Full Text] [Related]
20. Host-cell antigen potentiated by incomplete growth cycle of influenza virus.
Haller O; Lindenmann J
J Natl Cancer Inst; 1975 Feb; 54(2):459-64. PubMed ID: 1167598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
